These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 28242255)
1. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease. Domellöf ME; Lundin KF; Edström M; Forsgren L Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255 [TBL] [Abstract][Full Text] [Related]
2. Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease. Yoo HS; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee PH J Neurol; 2019 Jul; 266(7):1601-1610. PubMed ID: 31011798 [TBL] [Abstract][Full Text] [Related]
3. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. Gjerde KV; Müller B; Skeie GO; Assmus J; Alves G; Tysnes OB Acta Neurol Scand; 2018 Dec; 138(6):508-514. PubMed ID: 30058142 [TBL] [Abstract][Full Text] [Related]
4. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Baba T; Kikuchi A; Hirayama K; Nishio Y; Hosokai Y; Kanno S; Hasegawa T; Sugeno N; Konno M; Suzuki K; Takahashi S; Fukuda H; Aoki M; Itoyama Y; Mori E; Takeda A Brain; 2012 Jan; 135(Pt 1):161-9. PubMed ID: 22287381 [TBL] [Abstract][Full Text] [Related]
5. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease. Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942 [TBL] [Abstract][Full Text] [Related]
6. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease. Kang SH; Lee HM; Seo WK; Kim JH; Koh SB J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667 [TBL] [Abstract][Full Text] [Related]
7. Olfactory dysfunction and dementia in Parkinson's disease. Takeda A; Baba T; Kikuchi A; Hasegawa T; Sugeno N; Konno M; Miura E; Mori E J Parkinsons Dis; 2014; 4(2):181-7. PubMed ID: 24625830 [TBL] [Abstract][Full Text] [Related]
8. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease. Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810 [TBL] [Abstract][Full Text] [Related]
10. Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction. Versace V; Langthaler PB; Sebastianelli L; Höller Y; Brigo F; Orioli A; Saltuari L; Nardone R J Neurol Sci; 2017 Jun; 377():55-61. PubMed ID: 28477708 [TBL] [Abstract][Full Text] [Related]
11. Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease. Rossi M; Perez-Lloret S; Millar Vernetti P; Drucaroff L; Costanzo E; Ballesteros D; Bril A; Cerquetti D; Guinjoan S; Merello M Mov Disord; 2015 Aug; 30(9):1275-9. PubMed ID: 26096632 [TBL] [Abstract][Full Text] [Related]
12. [Severe olfactory dysfunction is a predictor of dementia with Parkinson's disease]. Takeda A Rinsho Shinkeigaku; 2013; 53(2):91-7. PubMed ID: 23470887 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ponsen MM; Stoffers D; Booij J; van Eck-Smit BL; Wolters ECh; Berendse HW Ann Neurol; 2004 Aug; 56(2):173-81. PubMed ID: 15293269 [TBL] [Abstract][Full Text] [Related]
15. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. Ponsen MM; Stoffers D; Wolters ECh; Booij J; Berendse HW J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):396-9. PubMed ID: 19965851 [TBL] [Abstract][Full Text] [Related]
16. Olfactory deficits and cognitive dysfunction in Parkinson's disease. Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138 [TBL] [Abstract][Full Text] [Related]
17. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings. Chahine LM; Weintraub D; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D; Mov Disord; 2016 Jan; 31(1):86-94. PubMed ID: 26293177 [TBL] [Abstract][Full Text] [Related]
18. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease. Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568 [TBL] [Abstract][Full Text] [Related]
19. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jennings D; Siderowf A; Stern M; Seibyl J; Eberly S; Oakes D; Marek K; JAMA Neurol; 2017 Aug; 74(8):933-940. PubMed ID: 28595287 [TBL] [Abstract][Full Text] [Related]
20. Comparison between four published definitions of hyposmia in Parkinson's disease. Kanavou S; Pitz V; Lawton MA; Malek N; Grosset KA; Morris HR; Ben-Shlomo Y; Grosset DG Brain Behav; 2021 Aug; 11(8):e2258. PubMed ID: 34190430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]